Effect of moxibustion with deqi on Aβ-receptor mediated transport and enzymatic degradation in hippocampus in rats with Alzheimer's disease.
10.13703/j.0255-2930.20210616-k0006
- Author:
Zhi-Mai LV
1
,
2
,
3
;
Dan-Dan HUANG
4
;
Ding-Yi XIE
5
;
Rui-Zhen YUE
5
;
Jin-Wei WANG
1
,
3
;
Wei-Feng LUO
6
;
Ri-Xin CHEN
5
Author Information
1. Department of Neurology, First Affiliated Hospital of Gannan Medical College, Ganzhou 341000, Jiangxi Province, China
2. 2Department of Neurology, Second Affiliated Hospital of Suzhou University, Suzhou 215004, Jiangsu Province
3. Ganzhou Key Laboratory of Noninvasive Neuromodulation, Ganzhou 341000, Jiangxi Province.
4. School of Basic Medicine, Gannan Medical College.
5. Department of Acupuncture and Moxibustion, Affiliated Hospital of Jiangxi University of CM, Nanchang 330006.
6. Department of Neurology, Second Affiliated Hospital of Suzhou University, Suzhou 215004, Jiangsu Province.
- Publication Type:Journal Article
- Keywords:
Alzheimer's disease (AD);
Aβ enzymatic degradation;
Aβ receptor mediated transport;
Point GV 14 (Dazhui);
deqi;
moxibustion
- MeSH:
Alzheimer Disease/therapy*;
Amyloid beta-Peptides/genetics*;
Angiotensin-Converting Enzyme 2;
Animals;
Apolipoproteins E/metabolism*;
Hippocampus/metabolism*;
Male;
Moxibustion;
Rats;
Rats, Sprague-Dawley
- From:
Chinese Acupuncture & Moxibustion
2022;42(8):899-906
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the clinical effect of moxibustion with deqi on Alzheimer's disease (AD) rats, and evaluate its effect on β-amyloid (Aβ) transport and enzymatic degradation proteins, to explore its molecular mechanism for improving cognitive function.
METHODS:Sixty SPF-grade male SD rats were randomly divided into a blank group (8 rats), a sham-operation group (8 rats) and a model establishment group (44 rats). The rats in the model establishment group were injected with Aβ1-42 at bilateral ventricles to establish AD model. Among the 38 rats with successful model establishment, 8 rats were randomly selected as the model group, and the remaining rats were treated with mild moxibustion at "Dazhui" (GV 14), once a day, 40 min each time, for 28 days. According to whether deqi appeared and the occurrence time of deqi, the rats were divided into a deqi group (12 rats), a delayed deqi group (10 rats) and a non-deqi group (8 rats). After the intervention, the Morris water maze test was applied to evaluate the cognitive function; the HE staining was applied to observe the brain morphology; the Western blot method was applied to measure the protein expression of Aβ and its receptor mediated transport [low-density lipoprotein receptor-related protein (LRP) 1, receptor for advanced glycation end products (RAGE), apolipoprotein E (ApoE)] and enzymatic degradation [neprilysin (NEP), insulin degrading enzyme (IDE), endothelin converting enzyme (ECE)-1 and angiotensin converting enzyme (ACE) 2].
RESULTS:Compared with the sham-operation group, in the model group, the escape latency was prolonged (P<0.01), and the times of platform crossing and the ratio of platform quadrant to total time were reduced (P<0.01); the brain tissue was seriously damaged; the expression of hippocampal Aβ and RAGE was increased (P<0.01), and the expression of hippocampal LRP1, ApoE, NEP, IDE, ECE-1 and ACE2 was decreased (P<0.01). Compared with the model group, the escape latency was shortened in the deqi group (P<0.05, P<0.01), and the escape latency in the delayed deqi group and the non-deqi group was shortened from Day 2 to Day 5 (P<0.05, P<0.01), and the times of platform crossing and the ratio of platform quadrant to total time were increased in the deqi group and the delayed deqi group (P<0.01, P<0.05); the brain damage in each moxibustion group was reduced, which was smallest in the deqi group, followed by the delayed deqi group and the non-deqi group; the expression of Aβ and RAGE was decreased (P<0.01, P<0.05) and the expression of LRP1 and IDE was increased in each moxibustion group (P<0.01, P<0.05); the expression of ApoE was increased in the deqi group and the delayed deqi group (P<0.01, P<0.05); the expression of NEP was increased in deqi group (P<0.05), and the expression of ECE-1 and ACE2 was increased in the deqi group and the delayed deqi group (P<0.05). Compared with the delayed deqi group and the non-deqi group, the escape latency in the deqi group was shortened from Day 3 to Day 5 (P<0.05), and the times of platform crossing and the ratio of platform quadrant to total time were increased (P<0.05, P<0.01). Compared with the non-deqi group, the expression of Aβ was reduced (P<0.05), the expression of LRP1 and ApoE was increased in the deqi group (P<0.05). The expression of NEP in the deqi group was higher than that in the delayed deqi group and the non-deqi group (P<0.05).
CONCLUSION:Compared with non-deqi, moxibustion with deqi could promote Aβ transport and degradation, thereby reducing Aβ level in the brain and improving cognitive function for AD rats.
